Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders
- 31 July 1999
- journal article
- Published by Elsevier BV in Fertility and Sterility
- Vol. 72 (1), 32-40
- https://doi.org/10.1016/s0015-0282(99)00184-3
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndromeFertility and Sterility, 1998
- Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome?Human Reproduction, 1998
- Treatment of hyperinsulinaemia in polycystic ovary syndrome?Human Reproduction, 1998
- Clinical and hormonal effects of the combination gonadotrophin- releasing hormone agonist plus oral contraceptive pills containing ethinyl-oestradiol (EE) and cyproterone acetate (CPA) versus the EE-CPA pill alone on polycystic ovarian disease-related hyperandrogenismsHuman Reproduction, 1997
- Association of the Steroid Synthesis Gene Cyp11a with Polycystic Ovary Syndrome and HyperandrogenismHuman Molecular Genetics, 1997
- Relationship Between Insulin Sensitivity and Plasma Leptin Concentration in Lean and Obese MenDiabetes, 1996
- Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.JCI Insight, 1995
- Hyperandrogenic DisordersClinical Obstetrics and Gynecology, 1990
- Suppression of Hyperandrogenism Does not Improve Peripheral or Hepatic Insulin Resistance in the Polycystic Ovary Syndrome*Journal of Clinical Endocrinology & Metabolism, 1990
- Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome.JCI Insight, 1989